In The News
ALZFORUM.ORG | August 24, 2018
A lot can happen in a year.
Specialty Pharmacy Times | August 17, 2018
A new technology allows researchers to use brain biomarker neurofilament light chain (NfL) to uncover insights into the development and progression of neurological diseases, such as multiple sclerosis (MS).
STAT: First Opinion | May 16, 2018
By: Kevin Hrusovsky
MD+DI | March 21, 2018
Quanterix teams up with DestiNA to develop assays to detect liver toxicity in patients.
Bloomberg | February 05, 2018
Bloomberg reporter Anne Mostue interviews Kevin Hrusovsky in segment called, "The Race to Diagnose CTE in the Living"
Quartz | February 03, 2018
"What we need is collaboration among scientists, researchers, the NFL and other contact sports governing bodies to develop a blood test that can be used to monitor players’ brain health, as a blood test is a better alternative to CT scans and subjective tests that are entrenched in current protocol…